Trial Profile
Impact of switching from rosuvastatin to any other lipid lowering treatment : An observational, retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Adverse reactions
- 25 Oct 2016 New trial record
- 26 Sep 2016 Results published in the Advances in Therapy